Starling Oncology (STLN) Receivables (2020 - 2026)
Analysis
Starling Oncology (STLN) Receivables (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.73 Bn | 89.71 Bn | 15.19 Bn | 12.28 Bn |
| 2 | Tenet Healthcare | 22.05 Bn | 19.88 Bn | 4.45 Bn | 2.91 Bn |
| 3 | Encompass Health | 12.13 Bn | 12.00 Bn | 1.34 Bn | 687.30 Mn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 3.03 Bn |
| 5 | Universal Health Services | 10.12 Bn | 9.98 Bn | 3.29 Bn | 2.80 Bn |
| 6 | Ensign | 9.97 Bn | 9.64 Bn | 306.24 Mn | 676.80 Mn |
| 7 | Chemed | 6.91 Bn | 6.87 Bn | 221.47 Mn | 188.63 Mn |
| 8 | Pacs | 6.73 Bn | 6.57 Bn | 338.46 Mn | 723.91 Mn |
| 9 | Concentra Group Holdings Parent | 4.30 Bn | 4.14 Bn | 192.10 Mn | 299.82 Mn |
| 10 | Starling Oncology | 613.55 Mn | 572.46 Mn | 27.17 Mn | 66.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.71 Mn |
| Mar 31, 2026 | 59.45 Mn |
| Dec 31, 2025 | 58.98 Mn |
| Sep 30, 2025 | 59.98 Mn |
| Jun 30, 2025 | 55.94 Mn |
| Mar 31, 2025 | 49.67 Mn |
| Dec 31, 2024 | 48.32 Mn |
| Sep 30, 2024 | 54.86 Mn |
| Jun 30, 2024 | 54.37 Mn |
| Mar 31, 2024 | 59.13 Mn |
| Dec 31, 2023 | 42.45 Mn |
| Sep 30, 2023 | 48.91 Mn |
| Jun 30, 2023 | 46.89 Mn |
| Mar 31, 2023 | 46.38 Mn |
| Dec 31, 2022 | 39.87 Mn |
| Sep 30, 2022 | 35.38 Mn |
| Jun 30, 2022 | 29.37 Mn |
| Mar 31, 2022 | 25.79 Mn |
| Dec 31, 2021 | 20.48 Mn |
| Dec 31, 2020 | 17.26 Mn |